Medical records of sequential, non-selected patients with lung cancer who were treated at the Oncology Unit, Sotiria General Hospital, Athens, Greece between January 2015 and June 2018 were reviewed. Download pdf here
Greece is a South European country, located at the east part of the Mediterranean basin and the southern edge of the Balcan Peninsula, with a population of 10,720,000 in 2019.In the past decade, Greece’s mixed economy has gradually recovered from the financial deficit crisis that burst out in 2009 and led to the supervised funding of the country from the […]
“Clinical utility of thoracic endosonography (EBUS-EUS b) in mediastinal staging of patients with Non Small Lung Cancer : comparison with intergrated PET-CT – a real life prospective study in Greece”. Serafeim Chrysikos, Ioannis Gkiozos, Katerina Dimakou et all, in Journal of Thoracic Diseases, 12 (10) :5657-5666, 2020. One hundred and thirty patients were eligible for […]
“Modern Radiopharmaceuticals for lung cancer imaging with positron emission tomography/ computed tomography scan: A systematic review” by Athanasios Theodoropoulos, Ioannis Gkiozos, Georgios Kontopyrgias et all, in SAGE Open Med. 2020, September28;8. Lung cancer is one of the world’s most common and aggressive neoplasms. For this reason, it is important to have a timely diagnosis and […]
Immune checkpoint inhibitors (ICIs) are a newly developed component of cancer care that expands the treatment possibilities for patients. Their use has been associated with several immune-related adverse events, including ICIinduced sarcoidosis-like reactions. This article reviews the data concerning ICI-induced sarcoidosis-like reactions currently available in the medical literature. You can download the pdf, here
To determine whether PET/CT and brain MRI used in staging NSCLC can be accurate, reliable and cost-effective tools. NSCLC represents 80–85% of lung cancer and adequate information on the initial tumor staging is critical for planning an optimal therapeutic strategy. You can download the pdf, here
Lung cancer is the most common cancer in men and the third most common in women, worldwide. According to the World Health Organization (WHO), there are 1,590,000 deaths worldwide due to lung cancer, annually. Lung cancer is the second most common cancer in both sexes in the United States of America (USA), following prostate cancer […]
To review the use of brachytherapy as an adjuvant therapy to reduce recurrences after sublobar resections and as a palliation to patients with inoperable disease. A review of all published studies was performed to identify the recurrence rate after brachytherapy adjuvant to sublobar resection and assess the palliation of symptoms and the complications of brachytherapy […]
Epithelioid hemangioenthothelioma(EH) is a rare vascular neoplasm of endothelial origin. It most commonly develops in the lung and liver, but may also arise from any organ, and typically displays an intermediate clinical behavior between haemangioma and angiosarcoma. Download the pdf here
Although interventional management of malignant central airway obstruction (mCAO) is well established, its impact on survival and quality of life (QoL) has not been extensively studied.Aim: We prospectively assessed survival, QoL and dyspnea (using validated EORTC questionnaire) in patients with mCAO 1 day before interventional bronchoscopy, 1 week after and every following month, in comparison […]